|
Abstract Objective] To explore clinical efficacy of edaravone for the treatment of cerebral infarction .[Methods] A total of 64 patients with cerebral infarction in our hospital form Jan .2012 to Dec .2013 were randomly selected .All patients were admitted to the hospital for the diagnosis and treatment within 24h of on‐set .These patients were randomly divided into experimental group( n=32) and control group( n =32) .The control group was given intravenous instillation with conventional Xuesaitong needle ,while the experimental group was given edaravone based on the treatment of control group .The treatment results of two groups were observed .[Results] In experimental group ,31 patients were effective treatment ,and 1 patient was invalid , and the effective rate was 96 .9% (31/32) .In control group ,30 patients were effective treatment ,and 2 pa‐tients were invalid ,and the effective rate was 93 .8% (30/32) .There is no significant difference in the total ef‐fective rate between two groups .Compared with before treatment ,NIHSS score and Bathel index of two groups after treatment were obviously improved(all P<0 .05) ,and those in experimental group were obvious‐ly better than the control group ,and there was significant difference(all P<0 .05) .[Conclusion]Edaravone for early treatment of cerebral infarction can improve the symptoms of neurologic impairment .Therefore ,it is worthy of clinical promotion .
|
|
|
|
|
|
2014, Vol. 31 
